Related references
Note: Only part of the references are listed.Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer
G. Attard et al.
BRITISH JOURNAL OF CANCER (2008)
Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer
Karin G. Hermans et al.
CANCER RESEARCH (2008)
Characterization of TMPRSS2 : ETV5 and SLC45A3 : ETV5 gene fusions in prostate cancer
Beth E. Helgeson et al.
CANCER RESEARCH (2008)
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A. Tomlins et al.
NATURE (2007)
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer
Karin G. Hermans et al.
CANCER RESEARCH (2006)
TMPRSS2:: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
Sven Perner et al.
CANCER RESEARCH (2006)
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer
Jianghua Wang et al.
CANCER RESEARCH (2006)
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer
SA Tomlins et al.
CANCER RESEARCH (2006)
ETS transcription factors and their emerging roles in human cancer
A Seth et al.
EUROPEAN JOURNAL OF CANCER (2005)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Molecular biology of the Ets family of transcription factors
T Oikawa et al.
GENE (2003)
Share Paper
